Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

“…For panel B, error bars represent the standard error of the mean (<i>n</i> = 25), and statistical significance was analyzed by one-way ANOVA with a Tukey post hoc test (*<i>p</i> < 0.05 and **<i>p</i> < 0.01). …”

List of primers used in this study. by Haotian Ma (11100492)

“…<div><p><i>Listeria monocytogenes</i> is a significant zoonotic pathogen capable of forming biofilms on food and other materials, representing a considerable risk to human health and animal husbandry. …”

Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

“…<p>(A–C) Overexpressed MALS-1::Scarlet protein colocalizes with mitochondria. …”

Loss of RBM-26 causes mitochondria dysfunction in PLM. by Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. by Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

The spheroid assay is used to assess long-term effects of therapy on tumor cell by culturing the tumor cells in a micro-mass, which is a 3D tumor mass used as a surrogate for in vi... by Bryan S. Margulies (21492667)

“…<p>(A) MCF7 tumor cell micro-mass cultures (purple staining) treated with 0-, 1-, 2-, 2.5-, 5-, and 10-mM N-allyl noroxymorphone doses, after 336-hours, produced a significant decrease of 41.9% and 68.1% in micro-mass areas for the 5- and 10-mM N-allyl noroxymorphone concentrations, respectively (* = p < 0.014 and **** = p < 0.0001). …”

Determinants of childbirth in private HF among women who had a live birth one year before the survey, NDHS 2022. by Resham B. Khatri (10949429)

Supplementary Table S2 from Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4⁺ T Cells by Signe Caksa (16745174)

Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

“…The Nrf2 pathway and its related proteins involved in modifying P-glycoprotein (P-gp) expression were clarified by a series of immunoblot analyses.</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

E (soil aggregate stability energy) is the amount of energy required when 99% of the soil is disrupted, Ecrit (soil critical stabilization energy) is the energy required when the i... by Xiaoxu Zhu (11764430)

Fig 1 - Fusing multisensory signals across channels and time by Swathi Anil (17382903)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Table 1_DYRK1A roles in human neural progenitors.xlsx by Jeremie Courraud (20871932)

“…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”

Data Sheet 1_DYRK1A roles in human neural progenitors.docx by Jeremie Courraud (20871932)

“…In addition, DYRK1A-KD led to a reduction in p21 protein levels, despite an increase in the expression of a minor transcript variant for this gene, and a decrease in ERK pathway activation.…”

Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). by Jinho Lee (587173)

A set of 4 criteria for the needs of multi-criteria evaluation ‐ combinations B1– B5. by Roman Vavrek (13200141)

A set of 3 criteria for the needs of multi-criteria evaluation ‐ combinations C1–C10. by Roman Vavrek (13200141)

A set of 2 criteria for the needs of multi-criteria evaluation ‐ combinations D1–D10. by Roman Vavrek (13200141)